Dyslipidaemia in Type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone

Dyslipidaemia in Type 2 diabetes: effects of the thiazolidinediones pioglitazone and rosiglitazone

Saved in:
Bibliographic Details
Published in:Diabetic medicine Vol. 22; no. s3; pp. 6 - 10
Main Authors: Mukhtar, R., Reckless, J. P. D.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing, Ltd 01-07-2005
Subjects:
Diabetes Mellitus, Type 2 - complications
Evidence-Based Medicine
Humans
Hyperlipidemias - drug therapy
Hyperlipidemias - etiology
Hypoglycemic Agents - therapeutic use
Meta-Analysis as Topic
Thiazolidinediones - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:istex:0B54AEA8023921027B24F31EC6681C704CFAF41C
ArticleID:DME1711C
ark:/67375/WNG-PVF3PJSQ-R
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0742-3071
1464-5491
DOI:10.1111/j.1466-5468.2005.01711c.x